BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29672827)

  • 21. [Clinical characteristics and survival of peripheral T-cell lymphoma-not otherwise specified: a report of 57 cases].
    Chen X; Dong DF; Wu YY; Huang HY; Liang J; Li EX
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):916-9. PubMed ID: 20193331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
    Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
    Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival advantage with the addition of radiation therapy to chemotherapy in early stage peripheral T-cell lymphoma, not otherwise specified.
    Zhang XM; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Zhou LQ; Liu XF; Yu ZH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1051-6. PubMed ID: 23021436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
    Hong H; Fang X; Wang Z; Huang H; Lam ST; Li F; Peng C; Tian Y; Lin S; Lin T
    Leuk Lymphoma; 2018 Dec; 59(12):2911-2916. PubMed ID: 29909754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified.
    Zhang W; Wang L; Zhou D; Cui Q; Zhao D; Wu Y
    Leuk Lymphoma; 2011 Jan; 52(1):46-52. PubMed ID: 21077742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Platelet Count in Patients with Peripheral T Cell Lymphoma.
    Choi M; Lee JO; Jung J; Lee JY; Lee E; Lee H; Bang SM; Eom HS; Lee JS
    Acta Haematol; 2019; 141(3):176-186. PubMed ID: 30814469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.
    Yi JH; Ryu KJ; Ko YH; Kim WS; Kim SJ
    Cytokine; 2019 Jan; 113():371-379. PubMed ID: 30327172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
    Koyama S; Fujisawa S; Watanabe R; Itabashi M; Ishibashi D; Ishii Y; Hattori Y; Nakajima Y; Motohashi K; Takasaki H; Kawasaki R; Hashimoto C; Yamazaki E; Koharazawa H; Takemura S; Tomita N; Sakai R; Motomura S; Nakajima H
    Int J Lab Hematol; 2017 Feb; 39(1):112-117. PubMed ID: 27885817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era.
    Petrich AM; Helenowski IB; Bryan LJ; Rozell SA; Galamaga R; Nabhan C
    Br J Haematol; 2015 Mar; 168(5):708-18. PubMed ID: 25382108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
    Hapgood G; Civallero M; Stepanishyna Y; Vose J; Cabrera ME; Advani RH; Pileri SA; Manni M; Horwitz SM; Foss FM; Hitz F; Radford J; Dlouhy I; Chiattone C; Kim WS; Skrypets T; Nagler A; Trotman J; Luminari S; Federico M
    Blood Adv; 2023 Sep; 7(17):5047-5054. PubMed ID: 37163360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified.
    Shim H; Jang S; Huh J; Yoon DH; Suh C; Park CJ
    Ann Lab Med; 2019 Mar; 39(2):200-204. PubMed ID: 30430783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum cholesterol levels predict inferior prognosis and improve prognostic index scoring for peripheral T-cell lymphoma, unspecified.
    Tang J; Yin H; Wu JZ; Xia Y; Liang JH; Chen RZ; Zhu HY; Fan L; Li JY; Wang L; Xu W
    Leuk Res; 2021 Apr; 103():106534. PubMed ID: 33631620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
    Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
    Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS.
    Cao Z; Wang X; Xue X; Feng X
    Ann Hematol; 2024 Mar; 103(3):869-883. PubMed ID: 38040859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.
    Fuji S; Kida S; Nakata K; Morishima T; Miyashiro I; Ishikawa J
    Ann Hematol; 2021 Jan; 100(1):157-165. PubMed ID: 33089366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.
    Mitrovic Z; Perry AM; Suzumiya J; Armitage JO; Au WY; Coiffier B; Holte H; Jaffe ES; Monserrat E; Rajan SK; Savage KJ; Tobinai K; Vose JM; Weisenburger DD
    Am J Hematol; 2012 Aug; 87(8):790-4. PubMed ID: 22488678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of peripheral blood stem cell transplantation for 38 patients with peripheral T-cell lymphoma.
    Bo J; Zhao Y; Zhang S; Hua W; Wang S; Gao C; Wang Q; Li H; Yu L
    J Cancer Res Ther; 2016; 12(3):1189-1197. PubMed ID: 28054534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.